Please assess the completion status of the following clinical trial:

Trial Title: Single-dose Linaclotide for Capsule Endoscopy Preparation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Schedule for video endoscopy at UVHS~* Ability to speak, read and write English~* Age \>18~* Able to provide consent~Exclusion Criteria:~* Prisoner~* Woman who is currently pregnant or breastfeeding~* Allergy to linaclotide~* Patients with known or suspected mechanical gastrointestinal obstruction

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention (Type: EXPERIMENTAL): Linaclotide 290mcg

Based on this trial design, predict the completion outcome and termination type (if applicable).